Elysium Health Inc.

Apr 23, 2020

Elysium Health(TM) Announces Exclusive License of DNA Methylation Biomarkers of Personalized Health and Aging and Cellular Senescence from Yale University

Dec 23, 2019

Elysium Health(TM) Announces $40 Million Series C Financing Led by GISEV Family Office

Nov 21, 2019

Elysium Health(TM) Announces Clinical Trial to Explore the Effect of Basis(TM) on Liver Fat Accumulation in Healthy Adults with Fatty Liver (NAFL)

Aug 09, 2019

Elysium Health(TM) Announces Initiation of Clinical Trial to Explore the Effects of Basis(TM) and High-Intensity Interval Training (HIIT) on Muscle Metabolism and Exercise Performance

Sep 19, 2018

Elysium Health(TM) Responds to Baseless Allegations by Disgruntled Former Supplier

Mar 29, 2018

Elysium Health(TM) Granted Orphan Drug Designation for EH301 to Treat Amyotrophic Lateral Sclerosis (ALS)

Feb 01, 2018

Elysium Health(TM) and University of Oxford Name First Prize Fellowship Recipient Who Will Study Aging and Cellular Health

Nov 27, 2017

Elysium Health(TM) Announces Positive Data on Its Product BASIS Published in "Nature Partner Journals: Aging and Mechanisms of Disease"